Compared with normal healthy subjects, NAFLD/NASH patients present increased levels of ROS and lipid peroxidation products and decreased levels of antioxidant enzymes like SOD, CAT, and antioxidant compounds such as GSH [57], which has been proven by our results. The gene discussed is SOD1; the disease is metabolic dysfunction-associated steatotic liver disease.